Lee S Cohen
Examiner (ID: 17427, Phone: (571)272-4763 , Office: P/3739 )
Most Active Art Unit | 3739 |
Art Unit(s) | 3739, 3305, 3794, 0, 3736, 3311 |
Total Applications | 3720 |
Issued Applications | 3004 |
Pending Applications | 173 |
Abandoned Applications | 543 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17541037
[patent_doc_number] => 11306148
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-19
[patent_title] => Anti-NPR1 antibodies and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/657000
[patent_app_country] => US
[patent_app_date] => 2019-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 37
[patent_no_of_words] => 36610
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16657000
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/657000 | Anti-NPR1 antibodies and uses thereof | Oct 17, 2019 | Issued |
Array
(
[id] => 17665318
[patent_doc_number] => 11358999
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-14
[patent_title] => IL-12 heterodimeric Fc-fusion proteins
[patent_app_type] => utility
[patent_app_number] => 16/592656
[patent_app_country] => US
[patent_app_date] => 2019-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 195
[patent_figures_cnt] => 253
[patent_no_of_words] => 80991
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16592656
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/592656 | IL-12 heterodimeric Fc-fusion proteins | Oct 2, 2019 | Issued |
Array
(
[id] => 15681331
[patent_doc_number] => 20200095329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => ANTI-CD30 ANTIBODIES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/580483
[patent_app_country] => US
[patent_app_date] => 2019-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 303
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16580483
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/580483 | Anti-CD30 antibodies and methods for treating CD30+ cancer | Sep 23, 2019 | Issued |
Array
(
[id] => 15681333
[patent_doc_number] => 20200095330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => SYSTEM AND METHOD FOR THE DEVELOPMENT OF CD30 BISPECIFIC ANTIBODIES FOR IMMUNOTHERAPY OF CD30+ MALIGNANCIES
[patent_app_type] => utility
[patent_app_number] => 16/580625
[patent_app_country] => US
[patent_app_date] => 2019-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 347
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16580625
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/580625 | CD30 bispecific antibodies and method of immunotherapy of CD30+ malignancies | Sep 23, 2019 | Issued |
Array
(
[id] => 15768847
[patent_doc_number] => 20200115441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => METHODS FOR TREATING INFLAMMATION USING ANTIBODIES TO KALLIDIN AND DES-ARG10-KALLIDIN
[patent_app_type] => utility
[patent_app_number] => 16/580603
[patent_app_country] => US
[patent_app_date] => 2019-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28755
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16580603
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/580603 | METHODS FOR TREATING INFLAMMATION USING ANTIBODIES TO KALLIDIN AND DES-ARG10-KALLIDIN | Sep 23, 2019 | Abandoned |
Array
(
[id] => 17587716
[patent_doc_number] => 11325972
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-10
[patent_title] => Methods of treatment of eosinophilic bronchitis with an anti-IL-5 antibody
[patent_app_type] => utility
[patent_app_number] => 16/575903
[patent_app_country] => US
[patent_app_date] => 2019-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7894
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16575903
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/575903 | Methods of treatment of eosinophilic bronchitis with an anti-IL-5 antibody | Sep 18, 2019 | Issued |
Array
(
[id] => 17171702
[patent_doc_number] => 20210325372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => METHOD TO ASSESS CAR FUNCTIONALITY
[patent_app_type] => utility
[patent_app_number] => 17/271767
[patent_app_country] => US
[patent_app_date] => 2019-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17271767
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/271767 | METHOD TO ASSESS CAR FUNCTIONALITY | Aug 29, 2019 | Pending |
Array
(
[id] => 17171724
[patent_doc_number] => 20210325394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => METHOD FOR PROVIDING INFORMATION ON THERAPEUTIC REACTION OF CANCER IMMUNOTHERAPY AND KIT USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/271441
[patent_app_country] => US
[patent_app_date] => 2019-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6910
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17271441
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/271441 | METHOD FOR PROVIDING INFORMATION ON THERAPEUTIC REACTION OF CANCER IMMUNOTHERAPY AND KIT USING SAME | Aug 27, 2019 | Pending |
Array
(
[id] => 17022332
[patent_doc_number] => 20210246203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING PROGRESSIVE NEURODEGENERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/772150
[patent_app_country] => US
[patent_app_date] => 2019-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11934
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16772150
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/772150 | Astrotactin1-based compositions and pharmaceutical formulations | Aug 20, 2019 | Issued |
Array
(
[id] => 16114483
[patent_doc_number] => 20200209264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => PIP2 AS A MARKER FOR HDL FUNCTION AND CARDIOVASCULAR DISEASE RISK
[patent_app_type] => utility
[patent_app_number] => 16/544356
[patent_app_country] => US
[patent_app_date] => 2019-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16544356
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/544356 | PIP2 AS A MARKER FOR HDL FUNCTION AND CARDIOVASCULAR DISEASE RISK | Aug 18, 2019 | Abandoned |
Array
(
[id] => 17698279
[patent_doc_number] => 11372000
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Antibodies recognizing genetic variants of NT-proBNP
[patent_app_type] => utility
[patent_app_number] => 16/538886
[patent_app_country] => US
[patent_app_date] => 2019-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14443
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16538886
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/538886 | Antibodies recognizing genetic variants of NT-proBNP | Aug 12, 2019 | Issued |
Array
(
[id] => 16650015
[patent_doc_number] => 10927178
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-23
[patent_title] => Anti-CXCR4 antibodies and antibody-drug conjugates
[patent_app_type] => utility
[patent_app_number] => 16/535477
[patent_app_country] => US
[patent_app_date] => 2019-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 28
[patent_no_of_words] => 58330
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16535477
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/535477 | Anti-CXCR4 antibodies and antibody-drug conjugates | Aug 7, 2019 | Issued |
Array
(
[id] => 17697126
[patent_doc_number] => 11370837
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Anti-TIGIT antibody and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/965687
[patent_app_country] => US
[patent_app_date] => 2019-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 24
[patent_no_of_words] => 23520
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16965687
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/965687 | Anti-TIGIT antibody and use thereof | Jul 24, 2019 | Issued |
Array
(
[id] => 15726833
[patent_doc_number] => 10611838
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-07
[patent_title] => C-KIT antibodies
[patent_app_type] => utility
[patent_app_number] => 16/521793
[patent_app_country] => US
[patent_app_date] => 2019-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 29050
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16521793
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/521793 | C-KIT antibodies | Jul 24, 2019 | Issued |
Array
(
[id] => 15527287
[patent_doc_number] => 20200055949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => TARGETED TGFss INHIBITION
[patent_app_type] => utility
[patent_app_number] => 16/522304
[patent_app_country] => US
[patent_app_date] => 2019-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16522304
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/522304 | Targeted TGFb inhibition | Jul 24, 2019 | Issued |
Array
(
[id] => 15023497
[patent_doc_number] => 20190322753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => CX3CR1-BINDING POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
[patent_app_type] => utility
[patent_app_number] => 16/505773
[patent_app_country] => US
[patent_app_date] => 2019-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16505773
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/505773 | CX3CR1-binding polypeptides comprising immunoglobulin single variable domains | Jul 8, 2019 | Issued |
Array
(
[id] => 15589775
[patent_doc_number] => 20200071422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => METHODS FOR INHIBITING ATHEROSCLEROSIS BY ADMINISTERING AN INHIBITOR OF PCSK9
[patent_app_type] => utility
[patent_app_number] => 16/505074
[patent_app_country] => US
[patent_app_date] => 2019-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15288
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16505074
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/505074 | Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody | Jul 7, 2019 | Issued |
Array
(
[id] => 17460332
[patent_doc_number] => 20220073637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/256553
[patent_app_country] => US
[patent_app_date] => 2019-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54053
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17256553
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/256553 | COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES | Jun 30, 2019 | Pending |
Array
(
[id] => 16824317
[patent_doc_number] => 20210139610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => COMPOSITIONS AND METHODS FOR MEDIATING EPS
[patent_app_type] => utility
[patent_app_number] => 17/256640
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17256640
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/256640 | COMPOSITIONS AND METHODS FOR MEDIATING EPS | Jun 27, 2019 | Pending |
Array
(
[id] => 15320909
[patent_doc_number] => 20200000784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => MATERIALS AND METHODS FOR TREATING VALVULAR HEART DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/457552
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16457552
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/457552 | Methods for treating aortic valve stenosis with a hedgehog pathway inhibitor | Jun 27, 2019 | Issued |